Please ensure Javascript is enabled for purposes of website accessibility

Why Clover Health Shares Fell 39% in July

By Jason Hawthorne – Aug 6, 2021 at 2:33PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The company had a lot going on last month and none of it was good.

What happened

Shares of healthcare technology company Clover Health (CLOV 6.50%) lost 39.4% in July, according to numbers from S&P Global Market Intelligence. Insider selling, the loss of its CFO, and the waning attention of meme-stock traders all contributed to the performance.

A doctor seeing an elderly patient in a checkup room while a third person observes.

Image source: Getty Images.

So what

In the long term, traders moving on from the stock isn't a bad thing. The fall puts it essentially right back where it was at the beginning of June.

CLOV Chart

CLOV data by YCharts

Even the insider selling isn't necessarily bad. After going public in January, the expiration of a 180-day lock-up period allowed those who received shares in its initial public offering (IPO) to sell. They can be forgiven for taking advantage of the 72% climb on no news in June. 

The bigger problem may be the loss of its chief financial officer after a little more than a year in the job to focus on the health of a family member. The exit comes less than two months after the company surprised analysts with its projection of 70,000 to 100,000 lives under contract this year in Medicare's new direct contracting program. Chamath Palihapitiya -- who helped bring the company public via a special purpose acquisition company (SPAC) -- had previously claimed it already had 200,000 under contract.

Now what

Now that Wall Street has a clearer picture of where the company stands, the stock should be less volatile. As for the finance chief, Clover is bringing in an industry veteran on an interim basis.

After a roller-coaster summer for the stock, investors will be eager to get an update from management when the company reports second-quarter earnings in mid-August. They'll be listening for progress in rolling out its Clover Assistant to more physicians and a better estimate of the lives covered in the direct contracting program.

Jason Hawthorne has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Nearly 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Clover Health Investments Stock Quote
Clover Health Investments
CLOV
$1.31 (6.50%) $0.08

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
349%
 
S&P 500 Returns
115%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/01/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.